Saliva Sampling and Testing Strategies for Screening AD Biomarkers Using a Portable Antibody Functionalized Bioanalyzer Platform
The saliva sampling prototype testing with bioanalyzer platform was conducted to verify the protein stability and platform capability prior to deployment in an AD dementia clinical trial in Ottawa. The team will now proceed with testing saliva samples from patients with different stages of AD pathology as established using amyloid PET scans (IMHR, Ottawa).
Authors
- Andrew Frank (ORCID: https://orcid.org/0009-0002-8587-7727)
- Rafal Iwasiow
- S. Johri (ORCID: https://orcid.org/0009-0003-9217-9035)
- Evgueni Doukhanine
- Amit Arora
- Organic Sensors and Devices Lab (OSDL)
- Ravi Prakash
- Dylan Layton‐Matthews
Institutions
- Bruyère (CA)
- Atotech (United States) (US)
- Carleton University (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108703
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 0.00